Zdrowie i gospodarka · 19/08/1999
FDA Amends Blood Regulations to Align with Industry Practices
The FDA is updating its biologics regulations to remove outdated requirements and align with current industry practices, effective immediately, as part of its 'Blood Initiative' to review and revise regulations related to blood, blood components, and Source Plasma.